Tag : Cannabinoid

Latest News

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

Newsemia
GB Sciences, Inc. announced significant preclinical results for their Parkinson’s disease (“PD”) formulations from the midterm report for their preclinical study being performed by Dr....
Pharma / Biotech

Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.

Newsemia
Related Articles Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice. Pharmacol...
Latest News

Study discovers paradoxical proinflammatory effect of endocannabinoids in the brain

Newsemia
A new study led by the Neuropharmacology Laboratory -NeuroPhar at UPF shows that increasing endocannabinoids in the brain may cause inflammation in specific brain areas...
Pediatrics

Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends

Newsemia
Clinical Pediatrics, Ahead of Print. Rising Δ9-tetrahydrocannabinol concentrations in modern cannabis invites investigation of the teratological implications of prenatal cannabis exposure. Data from Colorado Responds...
Latest News

Body's endocannabinoid system appears to be new target for drug development against OCD

Newsemia
The body’s endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated...
Latest News

Cannabidiol reduces cue-induced craving and anxiety in individuals with history of heroin abuse

Newsemia
Cannabidiol reduced cue-induced craving and anxiety in individuals with a history of heroin abuse, suggesting a potential role for it in helping to break the...
Gastroenterology

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Newsemia
Abdominal pain is common and persistent in patients with IBD. Available anti-inflammatory treatments often fail to relieve pain despite disease remission. Cannabinoid receptor agonists have...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy